Introduction
earliest serious disease manifestations. We and others Foetal somatic gene therapy during mid to late gestation hypothesised that the therapeutic cDNA gene construct has been suggested as a novel approach to prevent irrecould be administered to a CF foetus by delivery into the versible perinatal disease manifestation in particular for amniotic cavity and from there reach the gut and lung many inherited conditions. Early therapeutic gene appliepithelia by swallowing and foetal breathing movecation may also allow targeting of still expanding stem ments. 1, [7] [8] [9] [10] [11] cell populations of organ or cell systems inaccessible later The ideal vector systems for foetal gene therapy should in life and help to avoid immune sensitisation against the be able to transfer the gene of interest permanently to a therapeutic vector system or transgene protein product stem cell population, thereby allowing a lifetime correc-(for review see Ref. 1) .
tion of the disease. Retroviral vectors would be presently Since the amniotic fluid (AF) is swallowed by the foebest suited to meet this requirement. They have been tus, re-absorbed by the gastro-intestinal tract and then extensively investigated and used in several ex vivo excreted through the kidneys, 2 it should be possible to human gene therapy trials. [12] [13] [14] Because of their capability reach the intestinal tract by this route of administration.
to integrate into the host genome they could allow perThe foetus also displays episodes of breathing movemanent gene transfer into the frequently dividing foetal ments, leading to an influx of amniotic fluid into the cells, amongst which most likely a high percentage of lungs. 3 stem cells exist. The main present problems for the in vivo Cystic fibrosis (CF) is an interesting target disease for application of retroviral vectors remain their low titre foetal somatic gene therapy. The CFTR protein is already and their instability in vivo in the presence of some body expressed at high level in the airway epithelium during fluids. The efficiency of viral infection is for instance sigfoetal life, [4] [5] [6] suggesting that it may play an important nificantly reduced by serum, 15, 16 although some progress role during foetal development of this tissue. Enteral has recently been made to overcome this drawback. 17 We have observed a limited inhibitory effect of amniotic fluid (AF) on retroviral infection in vitro, due either to the we describe that virus-producer cells can be administered 2a and b) where they transduced differentiated epithelial cells, in the Eustachian tube (not shown), over the conto the amniotic cavity of foetal mice at 12 to 13 days post coitus (dpc). The cells engraft on the foetus and remain junctiva of the eye beneath the eyelid (data not shown) and the membrane surrounding the gut (still external at viable for several days producing viral particles which infect neighbouring cells.
this stage of development) (data not shown). The highest level of transgene expression in foetal cells was observed An alternative strategy to achieve permanent correction of genetic disease would be the repeated application at 24 h after injection of the EPC. No infection was observed in the pulmonary airways and the gastro-intesof a transiently expressing vector. Adenovirus is presently the most effective vector system for transient tinal tract beyond the larynx. We detected no inflammatory reaction linked to the presence of the EPC or the gene delivery which can be used as a good indicator of the tissues reached by different forms of application, virus.
Since neither of the two packaging cell lines was able because of its broad cell tropism. First generation adenovirus has been used for intra-amniotic delivery to rats, 8 to produce enough virus to mediate infection of the pulmonary airways and the gut, we decided to use adenomice 10, 11 and lambs. 10, 19 However, only Holzinger et al 11 were able to infect the airways of foetal mice by intravirus, which is presently the most efficient vector system, in a further attempt to infect these organ systems by amniotic delivery of adenovirus, albeit at very low efficiency.
intra-amniotic injection. We have injected first generation adenovirus into the amniotic cavity of 13 to 16 dpc pregnant MF1 mice.
Adenovirus administration Initially 1-6 × 10 8 p.f.u. AdRSV␤gal were injected into the Expression was monitored 24 h to 5 days after injection. We observed the highest level of transfection between 48 amniotic cavity of 13-14 dpc foetuses. Expression of the reporter gene was analysed histochemically between 24 and 72 h after injection, localised almost exclusively in the amniotic membranes (AM), the foetal skin and the and 120 h after injection. At 48-72 h after injection, we observed very high levels of reporter gene expression in buccal and nasal cavities. Transfection of the lower respiratory tract and the gut was only achieved when injecthe AM and in the foetal skin ( Figure 3 ) including the ocular region. The histological analysis of the skin contion was performed at 15 dpc, suggesting that the stage of development is crucial for lung and gut targeting.
firmed the high level of transduction of the epidermis (Figure 3b ). The median saggital section of the foetus (Figure 3a ) also showed infection in the buccal, nasal and
Results
sinusal cavities. Several layers of differentiated airway epithelial cells of these cavities were transduced (data not shown). Generally, we observed lower levels of Packaging cells administration We initially administered an ecotropic viral suspension expression at 24, 96 and 120 h after injection in comparison to 48 and 72 h. No expression was detected in the (2 × 10 5 to 5 × 10 5 viral particles) into the amniotic cavity of 13-14 dpc mouse foetuses. However, they failed to pulmonary airways, the alveoli or the gastro-intestinal tract when injection was performed in foetuses younger transduce any foetal tissue, including the extra-embryonic membranes. than 15 dpc. When the adenovirus vector was injected inadvertently Assuming that this was due to the relatively low virus titre and the inhibitory effect of amniotic fluid, 18 we into the thorax of one foetus, we observed transduction in the vicinity of the heart ( Figure 4 ) and of tissues of the decided to administer (1.5 × 10 5 to 2 × 10 6 ) ecotropic (EPC) and pantropic virus producer cells (PPC) respectthoracical wall following the path of the needle (not shown). ively into the amniotic cavity of 13-14 dpc foetuses. They should provide a continuous source of virus production To investigate whether the time of development might be crucial to obtain lung transfection, we injected the in vivo. Transgene expression of ␤-galactosidase was detected histochemically in both ecotropic and pantropic adenoviral vector into the amniotic cavity of 15 and 16 dpc foetuses. In six of the 23 foetuses injected on the 15 packaging cells and in neighbouring foetal cells after 24 and 48 h demonstrating the ability of the packaging cells dpc we found clear signs of transgene expression in the pulmonary airways, albeit with different degrees of not only to survive in the foetal environment but also to produce infectious viral particles. We detected transgene intensity in different experiments ( Figure 5 a-d). Infection of the airway epithelia, confirmed histologically by expression in most foetuses and in their amniotic membranes, but with a high variability from one foetus to nuclear ␤-galactosidase staining (Figure 5d ), was homogeneously spread through the pulmonary airways but another.
Both ecotropic and pantropic packaging cells showed a was not detected in either the trachea or the alveoli ( Figure 5 b-d) on this day. We also found efficient infecsimilar pattern of distribution and efficiency of infection. They were found abundantly embedded in the AM and tion of the upper enteral tract from the buccal cavity through the oesophagus to the pyloric end of the stomach replacing the epidermis of the skin (Figure 1 ). Focal oedema in the underlying dermis was observed in the areas (Figure 6a ), but not in the lower intestine. In spite of some endogenous ␤-galactosidase background activity, in the replaced by pantropic LZRNL-virus producing cells (Figure 1) . The packaging cells can be distinguished from intestine, a stronger staining and the nuclear localisation of the staining in the pyloric epithelium of the injected foetal cells by their large nuclei, multiple nucleoli and high nuclear:cytoplasmic ratio as well as by the intensity animals demonstrated genuine transgene expression (Figure 6b ) whereas non-injected controls show only of their staining for ␤-galactosidase activity (Figure 1a) .
Most of the transduced foetal cells were located in the weak cytoplasmic staining in the intestinal epithelia (Figure 6c, d) . Interestingly, after 15 dpc, the skin is much vicinity of seeded EPC. Transduced foetal cells were found in the nasal and buccal cavities, the larynx (Figure less infected than at earlier stages, while the AM are equ- Gene delivery by injection into the intra-amniotic cavity which could easily be performed by transabdominal In summary, we have observed a clear although not completely understood pattern of infection from day 13 administration under ultrasonographic guidance may become an attractive procedure for future application in to day 16. On days 13 and 14, we found frequent and strong transfection of the amniotic membranes, the skin human foetal gene therapy. Several groups have started to investigate foetal gene and somewhat less of the buccal/nasal cavity. On day 15, the skin was much less infected while the buccal/nasal delivery by intra-uterine surgery in sheep or intra-amniotic injection in mice and rats using retroviral and adenoregion was frequently and intensively stained. This was the only day on which we repeatedly achieved adenoviral vectors. [8] [9] [10] [11] 19 The mouse which is particularly attractive for these studies because of the unique opportvirus infection of the pulmonary epithelium and of the lower pyloric region in some foetuses. Hardly any infecunity to create transgenic models of human disease has only been used so far by McCray et al 10 and Holzinger et tion even of the skin or the amniotic membranes was observed on day 16 . Figure 7 shows a semi-quantitative al. 11 Only Holzinger's group could obtain infection of the lower airways, however only at low efficiency and on isoestimation of the transfection efficiency of the main tissues reflecting the general tendency of the transfection lated cells. To resolve this discrepancy and to investigate the prinpattern during foetal development. No signs of inflammation were detected after administration on any of ciple feasibility of this procedure further, we investigated intra-amniotic delivery of retroviral and adenoviral these days. 886 achieved in foetal mice. We also demonstrate efficient infection of the gastro-intestinal tract including the pyloric end of the stomach but not the lower intestine by intra-amniotic adenovirus vector delivery. When ␤-galactosidase activity is used as the transgenic marker gene this has to be stringently controlled by histological detection of nuclear staining because of the appearance of endogenous activity in the gut at this stage of development.
So far no investigators have studied the pattern of adenovirus infection at earlier stages of development and our results emphasise the importance of the precise time for efficient transfection of the lungs and gut during foetal development. Although there may be some breathing movements before 15 dpc, they are obviously not intense enough to take the virus into the lower airways against the general outward flow of the fluid from the lungs. The variability in the extent of transfection among foetuses may well be related to the frequency of breathing move- dpc may be due to the beginning of the keratinisation of deserves further investigation. We have not seen any inflammatory reactions, after administration of both ␤-galactosidase recombinant adenovirus and ␤-galactosidase recombinant retrovirus producing packaging cells. This could just be due to the single virus administration and short time of expression investigated. It may however be an indication of the immaturity of the cellular defence system at this stage of development. We assume that the decrease of adenovirus expression after 72 h is due to the rapid division of the infected foetal cells resulting in a dilution of the vector.
The observation that tissues of the thoracic wall, the peritoneum and the pericardium could be relatively easily infected by direct puncture at early develomental stages may be of interest in relation to early treatment of dermatological or muscular disorders. Reaching a particular stem cell population by topical injection of an integrating vector system may allow permanent correction of may be compensated somewhat by the greater stability of these viral particles. The invasive behaviour of these producer cells observed in the epidermis may be a serivectors at different times of gestation between the 13th and 16th dpc. We obtained transduction only with the ous drawback in the potential use of PCs as a vector system. However, the potential to produce replication-defecadenovirus vector and after injection of the retroviral packaging cell line. Before 15 dpc, the majority of foetal tive viral particles by these cells remains interesting and suggests that the development of a non-adhesive and tissues reached are those in immediate contact with the amniotic fluid such as the skin and the foetal membranes, non-invasive packaging cell line may allow a better distribution of the packaging cells in the foetal organism and or those accessible through an external orifice like the mouth, nose, ear and the ocular cavity. Only the pharynx enable them to reach more remote organ systems. Such a producer cell line could be fitted with a mechanism for and larynx were reached and no infection of the lower airways was obtained at these early stages. However, we programmed or inducible cell death, for instance by pretreatment of the cells with mitomycin C or gamma-irradirepeatedly achieve adenovirus infection of the lung and the gut on day 15. Although the extent of transgene ating before injection 20 or by introducing a drug-induced suicide pathway (eg thymidine kinase/gancyclovir). expression differed substantially between animals we demonstrate here for the first time that widespread distriThey could thus provide a continuous production of virus, allowing several cycles of infection before being bution of adenovirus vector infection of the pulmonary airways without infection of the alveolar epithelia can be destroyed by a suicide system. In summary, our experiments demonstrate the feasi-
Materials and methods
bility of intra-amniotic gene delivery to reach the foetal pulmonary airways and enteral system suggesting it as Surgical procedure and animals Intra-amniotic injections were performed by laparoa promising approach to foetal gene therapy, not only for cystic fibrosis. Other diseases associated with respiratory tomy 22 on 35 pregnant mice on days 13-16 dpc. The mice were anaesthetised by intra-muscular injection of a 1:2 failure, eg deficiency of surfactant protein B or ␣1 antitrypsin could be candidates for such an approach. Orni-(vol/vol) mixture of Rompun (20 mg/ml xylazine; Bayer UK, Bury St Edmunds, UK) and Vetalar (100 mg/ml ketathine transcarbamylase deficiency has been corrected in an animal model by transgene expression in the small mine hydrochloride, 0.01% benzethonium chloride as preservative; Parke-Davis Veterinary, Gwent, UK). An intestine 21 and more complex conditions causing gastrointestinal dysfunction such as Hirschprung's megacolon i.m. dose of 10 l/10 g induced 30-40 min of light anaesthesia. congenitum may also become treatable by gene application to the amniotic fluid. This work also demonstrates One horn of the uterus was carefully pulled out of the abdomen to completely expose it and the embryos were that the developmental window allowing efficient targeting will not only be determined by the aim to avoid injected consecutively with 20 to 50 l of retrovirus producer cells or five-fold diluted adenovirus vector, using immune response and germline transfection 1 but also by the developmental status of the targeted organ system. a 33-gauge Hamilton needle, through the uterus wall, With careful handling, a survival rate of foetuses of cells per millilitre in 10% FCS supplemented DMEM and kept on ice in this medium to prevent clumping. Before between 70 and 80% was reached.
injection, the cell suspension was warmed to 37°C and injected immediately.
Retroviral producer cells
The TELCeB/delPMOSAF cell line (EPC) generates replication-defective MoMLV-based ecotropic virions which
Adenoviral vector
The adenovirus AdRSV␤gal is a type 5 human virus carry the LacZ gene driven by the retroviral LTR promoter. These cells produce helper-free human compmade replication deficient by deletion of the E1 region with an expression cassette containing the E. coli LacZ lement resistant virus at titres of 1 × 10 7 IU/ml. 17 Pantropic vesicular stomatitis virus glycoprotein (VSVreporter gene (carrying a SV40 nuclear localisation signal) under control of the Rous sarcoma virus LTR. 24 The G) pseudotyped virus LZRNL was generated as previously described.
23 LacZ transcription is driven by the majority of the E3 region is also deleted. The viral titre X-gal staining and stained with haematoxylin/eosin for histological analysis.
